Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research
AUTOR(ES)
Scharfstein, Julio, Gomes, Juliana de Assis Silva, Correa-Oliveira, Rodrigo
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2009-07
RESUMO
Despite the wealth of information generated by trans-disciplinary research in Chagas disease, knowledge about its multifaceted pathogenesis is still fragmented. Here we review the body of experimental studies in animal models supporting the concept that persistent infection by Trypanosoma cruzi is crucial for the development of chronic myocarditis. Complementing this review, we will make an effort to reconcile seemingly contradictory results concerning the immune profiles of chronic patients from Argentina and Brazil. Finally, we will review the results of molecular studies suggesting that parasite-induced inflammation and tissue damage is, at least in part, mediated by the activities of trans-sialidase, mucin-linked lipid anchors (TLR2 ligand) and cruzipain (a kinin-releasing cysteine protease). One hundred years after the discovery of Chagas disease, it is reassuring that basic and clinical research tends to converge, raising new perspectives for the treatment of chronic Chagas disease.
Documentos Relacionados
- Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review
- Sickle cell disease: looking back but towards the future
- Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies
- Congenital Chagas disease: alert of research negligence
- Insights into Alzheimer disease pathogenesis from studies in transgenic animal models